Bovine endothelial cells |
50 –100 μM ciprostene (prostacyclin analog) inhibits cell proliferation |
[62] |
Mouse primary endothelial cells |
Increased cell proliferation in Pparβ/δ-null endothelial cells as compared to wild-type |
[63] |
Human primary endothelial cells |
100 μM carbaprostacyclin or 50 μM L165041 has no effect on annexin V-positive cells or caspase 3 activity |
[64] |
Human endothelial cells and a human endothelial cell line (EAHy926) |
0.1 μM GW501516 causes an increase in cell proliferation after 72 hours |
[65] |
Human primary endothelial cells |
0.01 – 0.1 μM GW501516 causes an increase in cell proliferation after 14 days |
[66] |
Human primary endothelial progenitor cells |
0.1 – 1.0 μM GW501516 causes an increase in cell proliferation after 8 days |
[67] |
Human primary endothelial cells |
1 – 100 μM carbaprostacyclin and 10-50 μM L165041 decrease H2O2-induced apoptosis |
[64, 68] |
Human primary endothelial progenitor cells |
0.1 – 1 μM GW501516 decrease hypoxia-induced apoptosis |
[67] |
Rat vascular smooth muscle cells |
1.0 μM iloprost (prostacyclin analog) inhibits cell proliferation |
[71] |
Rat vascular smooth muscle cells |
Overexpression of prostacyclin synthase inhibits cell proliferation |
[70] |
Bovine vascular smooth muscle cells |
3 –100 μM ciprostene (prostacyclin analog) inhibits cell proliferation |
[62] |
Human vascular smooth muscle cells |
0.1 – 10 μM prostacyclin analogs (iloprost, cicaprost, UT-15) inhibits cell proliferation |
[69] |
Rat vascular smooth muscle cells |
1.0 μM beraprost (prostacyclin analog) inhibits cell proliferation; mediated by PPARβ/δ |
[73] |
Rat vascular smooth muscle cells |
5 – 10 μM L165041 inhibits PDGF-induced cell proliferation inhibits cell proliferation |
[72] |
Mouse primary hepatocytes |
TNFα-induced incorporation of BrdU is enhanced in Pparβ/δ-null hepatocytes as compared to wild-type |
[19] |
Rat primary stellate cells |
10 μM L165041 increase cell proliferation |
[74] |
Mouse primary stellate cells |
Increased cell proliferation in Pparβ/δ-null stellate cells as compared to wild-type |
[19] |
Human lung fibroblasts |
0.1 – 10 μM treprostinil (prostacyclin analog) and 0.1 – 100 μM GW0742 inhibit cell proliferation |
[75] |
Mouse lung fibroblasts |
100 μM treprostinil (prostacyclin analog) inhibits cell proliferation; effect not found in Pparβ/δ-null fibroblasts |
[75] |
Rat cardiac fibroblasts |
10 μM GW501516 inhibits cell proliferation |
[76] |
Rat cardiac fibroblasts |
10 μM GW501516 inhibits cell proliferation |
[77] |
Mouse embryonic fibroblasts |
Overexpression of PPARβ/δ increases cell proliferation |
[78] |
Human proximal tubular epithelial cell line (HK-2) |
0.2 – 1.0 μM L165041 decrease H2O2-induced apoptosis |
[79] |
Human embryonic kidney epithelial cell line (HEK-293) |
Increased intracellular prostacyclin increases apoptosis; mediated by PPARβ/δ |
[81] |
Mouse inner medullary collecting duct cell line (IMCD-K2) |
10 μM GW501516 inhibits cell proliferation; 0.01 – 1.0 μM GW501516 has no effect on anisomycin-induced apoptosis |
[82] |